Remember, everyones gut is unique
There are also other practical reasons to prescribe these drugs in people with type 2 diabetes, because all three classes are associated with relatively low risk of hypoglycemic events, while patients treated with GLP-1RA and SGLT-2 inhibitors may also benefit from weight loss [11]
As data were collected as part of routine clinical practice, the robustness and completeness of the data and conclusions may be affected
By doing so, GLP1-S reduces cravings, suppresses food intake, and supports weight loss without affecting energy expenditure[2]
Battistelli S, Vittoria A, Stefanoni M, Bing C, Roviello F
Their efficacy in providing analgesia is comparable to oral NSAIDs in mild-to-moderate OA, with a substantially lower incidence of systemic side effects (Table 2) (Osteoarthritis Group of the Rheumatology and Immunology Physicians Branch of the Chinese Medical Doctor Association, 2024